1315 Capital

1315 Capital is a Philadelphia-based private equity firm founded in 2014 that focuses on providing growth and expansion capital to commercial-stage companies in the healthcare sector. The firm specializes in investing in specialty pharmaceuticals, medical technologies, and healthcare services, including digital health and cost containment solutions. It seeks to invest between $10 million and $20 million in companies with the potential to scale their revenues to approximately $100 million, which positions them well for acquisition or entry into public markets. By targeting niche market sub-segments, 1315 Capital aims to support high-quality management teams in transforming small platform companies into significant players within the healthcare industry.

Jordan Brown

Vice President

Edward Chan

Partner and Investment Team Member

Carter Cortazzi

Associate

Jessica Hou

Partner

Michael Koby

Co-Founder and Investment Team Member

Ryan Kraus

Vice President

Ian Li

Principal and Investment Team Member

Craig Matturro

Principal and Investment Team Member

Adele Oliva

Co-Founder, Partner and Member of Investment Team

Matthew Reber

Partner and Member of Investment Team

Gregory Stokes

Operating Partner

11 past transactions

Nutrisense

Series A in 2022
NutriSense, Inc. is a Chicago-based company established in 2019 that focuses on personalizing nutrition through advanced continuous glucose monitoring and machine learning technology. The company offers a monthly subscription service that includes a glucose sensor and a mobile application for tracking meals, activities, and fasting. NutriSense aims to help clients understand their metabolism and manage their health effectively by providing tailored dietary recommendations and access to personal dietitians. Through its innovative approach, NutriSense seeks to empower individuals to create a diet that is uniquely suited to their needs.

Onkos Surgical

Series C in 2021
Onkos Surgical Inc. is a company focused on providing innovative technologies and solutions for surgical oncologists, particularly in the treatment of musculoskeletal cancers and complex conditions. Established in 2014 and headquartered in Parsippany, New Jersey, Onkos Surgical offers products like GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D-printed limb salvage replacement. The company emphasizes precision orthopedics, leveraging expertise in patient imaging analysis and personalized surgical planning. By addressing the clinical challenges associated with tumor surgery, Onkos Surgical aims to deliver diverse solutions tailored to the needs of patients, including children, who may require specialized care.

miraDry

Acquisition in 2021
miraDry is a only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors. miraDry non-invasive procedure is safe and highly efficacious with a proven commercial and clinical track record.

Encore Dermatology

Debt Financing in 2019
Encore Dermatology is a privately held fully-integrated dermatology company that provides prescription therapies and medical devices to dermatologists. It provides a range of medical dermatology products, treating a number of topical disease states that enable patients to get improved skin care and treatment with ease. Encore Dermatology was established in 2015 and is headquartered in Malvern, Pennsylvania.

Biocoat

Acquisition in 2019
Biocoat, Incorporated is a developer and licensor of biomaterial coatings tailored for medical devices, focusing on lubricious hydrophilic coatings that enhance the performance of various applications. The company specializes in coatings suitable for vascular catheters, guide wires, stents, and other medical devices, ensuring they are non-thrombogenic, biocompatible, and abrasion-resistant. Biocoat offers a range of coating systems, including the HYDAK series, which caters to diverse medical applications such as endoscopy and ophthalmology. In addition to its product offerings, Biocoat provides comprehensive coating services, including development, verification testing, and manufacturing process support, to meet the specific design parameters of original equipment manufacturers and contract manufacturers. Founded in 1991 and headquartered in Horsham, Pennsylvania, Biocoat plays a crucial role in enhancing the usability and effectiveness of medical devices.

Centurion Service Group

Acquisition in 2018
Centurion Service Group has grown to become the largest used medical equipment auction house in the world, with warehouse locations in Chicago, Las Vegas, South Florida, and Dallas. Medical equipment buyers from around the world know to go to Centurion’s auctions for all their hospital equipment purchasing needs including radiology, anesthesia, lab, exam, patient monitoring, cardiology, endoscopy, surgery, instrumentation, disposables, and much more. With over 8,000 pieces of surplus medical equipment sold every month, it’s ideal as a single source for acquiring the wide range of used medical equipment they need and in the quantities they desire.

Misonix

Post in 2017
Misonix has long been at the forefront of ultrasound technology and is a world leader in the design, development, manufacturing, and marketing of ultrasonic surgical devices. Their innovative, ultrasonic platforms for surgical applications include aspirators for the removal of both soft and hard tissue, instruments for laparoscopic cutting and coagulation, devices for wound cleansing and debridement, products for precision bone cutting and sculpting, liposuction instrumentation for improving body aesthetics, and High Intensity Focused Ultrasound (HIFU) systems for the ablation of tumors.

Colorescience

Series C in 2017
Colorescience, Inc. specializes in the production and sale of mineral-based cosmetics and sunscreen products. Founded in 2000 and based in Carlsbad, California, the company offers a range of treatment products aimed at addressing various skin concerns, including pigmentation, redness, dark circles, and signs of aging, as well as catering to different skin types such as sensitive, oily, and dry skin. Its product line includes UV protectors, primers, foundations, and enhancers, all designed with high-quality ingredients and formulations. Colorescience distinguishes itself in the luxury aesthetic makeup market by focusing on efficacy and ease of use. The company distributes its products through a network of licensed physicians, luxury spas, retailers, and online channels, emphasizing its commitment to reducing skin cancer and other skin conditions.

Onkos Surgical

Series B in 2017
Onkos Surgical Inc. is a company focused on providing innovative technologies and solutions for surgical oncologists, particularly in the treatment of musculoskeletal cancers and complex conditions. Established in 2014 and headquartered in Parsippany, New Jersey, Onkos Surgical offers products like GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D-printed limb salvage replacement. The company emphasizes precision orthopedics, leveraging expertise in patient imaging analysis and personalized surgical planning. By addressing the clinical challenges associated with tumor surgery, Onkos Surgical aims to deliver diverse solutions tailored to the needs of patients, including children, who may require specialized care.

JDS Therapeutics LLC

Private Equity Round in 2015
JDS Therapeutics LLC is a healthcare company that develops and markets products aimed at physicians, healthcare delivery networks, and healthcare professionals. Founded in 2011 and headquartered in Purchase, New York, the company focuses on nutritional ingredients and pharmaceuticals targeting diabetes, women’s health, cardiovascular diseases, and weight management. Its product portfolio includes ZERAMAX, a medical food designed for diabetes management; JDS-CR-002, an oral prescription drug; JDS-CR-102, an injectable prescription drug; JDS-SI-002, a medical food for osteoporosis; and JDS-CR-007, a nutritional supplement for alleviating hot flashes. JDS Therapeutics also specializes in developing, patenting, and commercializing natural, bioactive compounds, holding over 100 issued and pending patents.

Onkos Surgical

Series A in 2015
Onkos Surgical Inc. is a company focused on providing innovative technologies and solutions for surgical oncologists, particularly in the treatment of musculoskeletal cancers and complex conditions. Established in 2014 and headquartered in Parsippany, New Jersey, Onkos Surgical offers products like GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D-printed limb salvage replacement. The company emphasizes precision orthopedics, leveraging expertise in patient imaging analysis and personalized surgical planning. By addressing the clinical challenges associated with tumor surgery, Onkos Surgical aims to deliver diverse solutions tailored to the needs of patients, including children, who may require specialized care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.